(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.34%) $78.11
(0.36%) $2.22
(-0.28%) $2 317.60
(-0.54%) $27.40
(-0.16%) $986.80
(0.14%) $0.931
(0.38%) $10.94
(0.13%) $0.800
(-0.01%) $91.43
Live Chart Being Loaded With Signals
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific...
Stats | |
---|---|
本日の出来高 | 845 176 |
平均出来高 | 949 818 |
時価総額 | 41.75B |
EPS | $0 ( 2024-05-02 ) |
次の収益日 | ( $0 ) 2024-07-30 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 31.35 |
ATR14 | $0.155 (0.07%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-01 | Bousbib Ari | Buy | 42 847 | Common Stock |
2024-03-01 | Bousbib Ari | Sell | 16 261 | Common Stock |
2024-03-01 | Bousbib Ari | Sell | 15 417 | Common Stock |
2024-03-01 | Bousbib Ari | Sell | 11 169 | Common Stock |
2024-03-01 | Bousbib Ari | Sell | 42 847 | Stock Appreciation Right |
INSIDER POWER |
---|
4.82 |
Last 100 transactions |
Buy: 392 287 | Sell: 364 416 |
ボリューム 相関
IQVIA Holdings Inc 相関
10 最も負の相関 | |
---|---|
CSLT | -0.824 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
IQVIA Holdings Inc 相関 - 通貨/商品
IQVIA Holdings Inc 財務諸表
Annual | 2023 |
収益: | $15.01B |
総利益: | $4.14B (27.56 %) |
EPS: | $7.39 |
FY | 2023 |
収益: | $15.01B |
総利益: | $4.14B (27.56 %) |
EPS: | $7.39 |
FY | 2022 |
収益: | $14.41B |
総利益: | $5.03B (34.89 %) |
EPS: | $5.82 |
FY | 2021 |
収益: | $13.87B |
総利益: | $4.64B (33.45 %) |
EPS: | $5.05 |
Financial Reports:
No articles found.
IQVIA Holdings Inc
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。